Skip to content

Acceptance of a Telemedical Intervention in Patients with COPD

Acceptance of a Telemedical Intervention in Patients with COPD - ATICO

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000239
Enrollment
50
Registered
2009-11-03
Start date
2010-01-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease (COPD) J44

Interventions

Group 1: In addition to a guideline-based therapy of COPD by his/her pneumologist, the patient experiences an intensive telehealth care with regular monitoring of vital signs (oxygen saturation, heart

Sponsors

Robert Bosch Healthcare GmbH
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. written consent 2. male or female ambulatory treated patients 3. patients with COPD - GOLD classification III and IV 4. patients with COPD - GOLD classification I and II -, with an inpatient treatment of COPD lasting not longer than 3 months 5. patient has blood pressure when resting not higher than 180/100 mmHg 6. patient has the cognitive ability and intention to use the Health Buddy® with its peripherals 7. patient has adequate knowledge of the German language 8. patient has an active telephone connection, preferably analogue 9. patient is motivated to take part in the trial

Exclusion criteria

Exclusion criteria: 1. patient is currently participating in another trial or finished participation within the previous 4 weeks 2. patient is pregnant or breastfeeding 3. patient currently has known malignant or virulent illnesses 4. patient has a severe restriction of movements (e.g. paresis after stroke) 5. patient is invasively ventilated

Design outcomes

Primary

MeasureTime frame
The patient´s compliance with the system as the primary outcome is measured by: 1. share of patients, who used the system more than two thirds of the available working days; 2. ratio of completely answered daily dialogues; 3. drop-out rate (percentage of patients who not continue to participate in the study until the final visit)

Secondary

MeasureTime frame
1. perceived security (SeCu-16) 2. patient´s acceptance of the programme 3. programme induced effort for healthcare professionals 4. healthcare professional´s acceptance of the therapy programme 5. number of acute exacerbations 6. health-related quality of life (SGRQ) 7. smoking status 8. number and type of hospitalisations 9. urgent visits

Countries

Germany

Contacts

Public ContactOrtud Karg

Asklepios Klinik Gauting

O.Karg@asklepios.com

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026